Every 35 minutes, someone in the U.S.

is diagnosed with glioblastoma. Glioblastoma is the most common and aggressive type of brain cancer—and progress has not moved fast enough. New treatment options are needed for patients—and genomic testing is critical to improving care and extending lives. That's why our focus is on accelerating new treatment options and improving what’s possible, so that patients have more than just the standard of care. #GlioblastomaFoundation #HopeLivesHere #TransformingGlioblastomaTherapy #GlioblastomaAwareness #BrainCancer #Glioblastoma